Select Issuer Clients

Select Issuer Clients

Issuer Client Profile

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is a clinical stage biopharmaceutical company, focused on the development and commercialization of novel therapeutics to treat rare life-threatening ("orphan") inflammatory-fibrotic diseases with clear unmet medical needs. Its lead product ResunabTM is a novel oral anti-inflammatory drug that is expected to commence Phase IIa clinical trials for the treatment of cystic fibrosis and diffuse scleroderma, pending U.S. Food and Drug Administration (FDA) approval of the Investigational New Drug Applications (INDs), expected to be filed in the second half of 2014.

View Website

Stock Info

Corbus Pharmaceuticals Holdings, Inc. NASDAQ: CRBP
Day Range
52 wk Range
Market Cap

Stock Quotes are delayed at least 15 minutes.

Issuer Client News Feed

For Investors

Want to take part in the next big idea?

Join Our Network

For Entrepreneurs

Want to explore how we add value?

Submit Your Business Plan